BioCryst

$10.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.34 (-11.35%) Today
+$0.43 (+4.11%) As of 1:32 PM UTC after-hours

Why Robinhood?

You can buy or sell BioCryst and other stocks, options, and ETFs commission-free!

About BCRX

BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. The listed name for BCRX is BioCryst Pharmaceuticals, Inc. Common Stock.

CEO
Jon P. Stonehouse
Employees
140
Headquarters
Durham, North Carolina
Founded
1986
Market Cap
1.74B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
7.40M
High Today
$11.64
Low Today
$10.37
Open Price
$11.07
Volume
7.84M
52 Week High
$12.90
52 Week Low
$1.58

BCRX Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.25 per share
Actual
-$0.34 per share
Replay Earnings Call

You May Also Like

IYE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure